2009

Goel A, Mittal A, Evstatiev R, Nemeth M, Kruis W, Stoltes M, Boland R & Gasche C. In vivo effects of mesalazine or E.coli Nissle 1917 on microsatellite instability in ulcerative colitis. Aliment Pharmacol Ther  2009; 30, 634–642

Geert R. D’Haens, MD,* Richard Fedorak, MD, Marc Lemann, MD, Brian G. Feagan, MD, Michael A. Kamm, MD, Jacques Cosnes, MD, Paul J. Rutgeerts, MD, Philippe Marteau, MD,  Simon Travis, MD, Jurgen Scholmerich, MD, Steven Hanauer, MD, William J. Sandborn, MD and the IOIBD Membership
Endpoints for Clinical Trials Evaluating Disease Modification and Structural Damage in Adults with Crohn’s Disease 2009
Inflamm Bowel Dis 2009;000:000–000 2009 Endpoints.pdf

2008

Geboes K, Colombel JF, Greenstein A, Jewell D, Sandborn W, Vatn M, Warren B, Riddell RH. Indeterminate colitis : A review of the concept – What’s in a name? Inflamm Bowel Dis 2008; 14: 860-7

Karel Geboes, MD, Jean-Frederic Colombel, MD, Adrian Greenstein, MD, Derek P. Jewell, MD, William J. Sandborn, MD, Morten H. Vatn, MD, Bryan Warren, MD, Robert H. Riddell, MD,
and The Pathology Task Force of the International Organization of Inflammatory Bowel Diseases (IOIBD; K.G., D.P.J, B.W., R.H.R.)
Indeterminate Colitis: A Review of the Concept — What’s in a Name?
Inflamm Bowel Dis 2008;14:850 – 857 Indeterminate.pdf

Studies as a result of IOIBD Grants

Hafner, S., A. Timmer, H. Herfarth, G. Rogler, J. Schölmerich, A. Schäffler, B. Ehrenstein, W. Jilg, C. Ott, U. Strauch, F. Obermeier:
The role of domestic hygiene in inflammatory bowel disease: Hepatitis A and worm infestations.
Eur. J. Gastroenterol. Hepatol.20, 561-566 (2008)

Ott, C., F. Obermeier, S. Thieler, D. Kemptner, A. Bauer, U. Strauch, J. Schölmerich, G. Rogler, A. Timmer:
The incidence of inflammatory bowel disease in a rural region of southern Germany – a prospective population based study.
Eur. J. Gastroenterol. Hepatol. 20, 917-923 (2008)

2007

Croagh C, Shepherd SJ, Berryman M, Muir JG, Gibson PR. A pilot study on the effect of reducing dietary FODMAP intake on bowel function in patients without a colon.  Inflamm Bowel  Dis  2007;13:1522-8.

Geert d’Haens, William J. Sandborn, Brian G. Feagan, Karel Geboes, Stephen B. Hanauer, E. Jan Irvine, Marc Lémann, Philippe Marteau, Paul Rutgeerts, Jurgen Schölmerich, and Lloyd R. Sutherland
A Review of Activity Indices and Efficacy End Points for Clinical Trials of
Medical Therapy in Adults With Ulcerative Colitis
Gastroenterology 2007;132:763–786
2007 A review of activity indices .pdf

Catherine Croagh, MB, BS, Susan J. Shepherd, BApplSci, Melissa Berryman, BApplSci, Jane G. Muir, PhD, and
Peter R. Gibson, MD
Pilot Study on the Effect of Reducing Dietary FODMAP
Intake on Bowel Function in Patients without a Colon
Inflamm Bowel Dis 2007;13:1522–1528
Pouch.pdf

Halfvarson J, Jess T, Bodin L, Järnerot G, Orholm M, Munkholm P, Binder V, Tysk C. Longitudinal concordance for clinical characteristics in a Swedish-Danish twin population with inflammatory bowel disease. Inflammatory Bowel Disease 2007;13:1536-1544.

D'Haens, G., W.J. Sandborn, B.G. Feagan, K. Geboes, S.B. Hanauer, E.J. Irvine, M. Lémann, P. Marteau, P. Rutgeerts, J. Schölmerich, L.R. Sutherland:
A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with ulcerative colitis.
Gastroenterology 132, 763-786 (2007)

2006

Halfvarson J, Jess T, Magnuson A, Montgomery S, Orholm M, Tysk C, Binder V, Järnerot G.. Environmental factors in inflammatory bowel disease; a co-twin control study of a Swedish-Danish twin population.Inflammatory Bowel Disease 2006;12: 925-33.

2005

Sachar DB, Bodian CA, Goldstein ES, Present DH, Bayless TM, Picco M, van Hogezand RA, Annese V, Schneider J, Korelitz BI, Cosnes J; Is perianal Crohn's disease associated with intestinal fistulization?
 Task Force on Clinical Phenotyping of the IOIBD.
Am J Gastroenterol. 2005 Jul;100(7):1547-9.

Studies as a result of IOIBD Grants

Zankel, E., G. Rogler, T. Andus, C.M. Reng, J. Schölmerich, A. Timmer:
Crohn's disease patient selection in a tertiary referral center – comparison with patients from a population based cohort.
Eur. J. Gastroenterol. Hepatol. 17, 395-401 (2005)

2004

Perl DP, Fogarty U, Harpaz N, Sachar DB. Bacterial-metal interactions: the potential role of aluminum and other trace elements in the etiology of Crohn's disease. Inflamm Bowel Dis 2004;10:881-3. 2004 IOIBD.pdf

2003

2002

William J. Sandborn, Brian G. Feagan, Stephen B. Hanauer, Herbert Lochs, Robert Lofberg, Robert Modigliani, Daniel H. Present, Paul Rutgeerts, Jurgen Scholmerich, Eduard F. Stange, and  Lloyd R. Sutherland
A Review of Activity Indices and Efficacy Endpoints for Clinical
Trials of Medical Therapy in Adults With Crohn’s Disease
Gastroenterology 2002;122:512–530
2002 Endpoints.pdf

2002

Sandborn, W.J., B.G. Feagan, S.B. Hanauer, H. Lochs, R. Löfberg, R. Modigliani, D.H. Present, P. Rutgeerts, J. Schölmerich, E.F. Stange, L.R. Sutherland:
A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease.
Gastroenterology 122, 512-530 (2002)

2001

2000

Geboes K, Riddell R, Öst Ä, Jensfelt B, Persson T, Löfberg R. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut 2000; 47: 404-9

Older Publications

Sutherland, L., S. Hanauer, J. Schölmerich:
Standards for Trials of Therapy in Inflammatory Bowel Disease.
Infl. Bowel Dis. 3, 277-283 (1997)

Goebell, H., M. Campieri, T. Gilat, S. Hanauer, B. Korelitz, K. Lauritsen, M. Malchow, F. Martin, M. Miglioli, R. Modigliani, D. Present, J. Schölmerich, L. Sutherland: 
Drug trials in Inflammatory Bowel Diseases 1993-1995. A Survey Conducted by the IOIBD.
Inflamm. Bowel Dis. 2, 265-267 (1996)

Campieri, M., H. Goebell, S. Hanauer, B. Korelitz, K. Lauritsen, H. Malchow, F. Martin, M. Miglioli, R. Modigliani, D. Present, J. Schölmerich, L.R. Sutherland:
Recommendations for New Trials of Currently Available Therapy by the IOIBD Task Force on Clinical Trials.
Infl. Bowel Dis. 1, 295-298 (1995)

Sachar DB, Luppescu NE, Bodian C, Shlien RD, Fabry TL, Gumaste VV. Erythrocyte sedimentation as a measure of Crohn's disease activity: opposite trends in ileitis versus colitis. J Clin Gastroenterol 1990; 12:643-6.

Greenstein AJ, Lachman P, Sachar DB, Springhorn J, Heimann T, Janowitz HD, Aufses AH, Jr Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms.  Gut 1988;
29:588-92.1988 ioibd gut.pdf